HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.

Abstract
Golden hamsters received Adriamycin (ADR), detorubicin (DTR), AD-32, or aclacinomycin (ACM) three times weekly at doses extrapolated from optimal doses in L1210 leukemia. Minimal early lesions of the myocardium were detected by electron microscopy in ACM-treated animals. These lesions were aggravated after several weeks of treatment but remained reversible. Lesions in AD-32-treated hamsters were slightly more marked than those seen in ACM-treated animals but were much less severe than those observed in ADR- or DTR-treated animals. Similarly, light microscopy revealed pathologic changes in the skin following ADR or DTR administration. These changes were not seen in animals receiving AD-32 or ACM.
AuthorsD Dantchev, V Slioussartchouk, M Paintrand, M Hayat, C Bourut, G Mathé
JournalCancer treatment reports (Cancer Treat Rep) Vol. 63 Issue 5 Pg. 875-88 (May 1979) ISSN: 0361-5960 [Print] United States
PMID455329 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibiotics, Antineoplastic
  • Naphthacenes
  • aclacinomycins
  • valrubicin
  • Aclarubicin
  • Doxorubicin
  • Daunorubicin
Topics
  • Aclarubicin (analogs & derivatives)
  • Animals
  • Antibiotics, Antineoplastic (adverse effects)
  • Cricetinae
  • Daunorubicin (administration & dosage, analogs & derivatives)
  • Doxorubicin (administration & dosage, adverse effects, analogs & derivatives)
  • Drug Administration Schedule
  • Heart (drug effects)
  • Leukemia L1210 (drug therapy)
  • Mesocricetus
  • Microscopy, Electron
  • Myocardium (ultrastructure)
  • Naphthacenes (administration & dosage, adverse effects)
  • Skin (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: